<author><surname>Lobo</surname> <given-names>A</given-names> </author><author><surname>Launer</surname> <given-names>LJ</given-names> </author><author><surname>Fratiglioni</surname> <given-names>L</given-names> </author><author><surname>Andersen</surname> <given-names>K</given-names> </author><author><surname>Di Carlo</surname> <given-names>A</given-names> </author><author><surname>Breteler</surname> <given-names>MM</given-names> </author><author><surname>Copeland</surname> <given-names>JR</given-names> </author><author><surname>Dartigues</surname> <given-names>JF</given-names> </author><author><surname>Jagger</surname> <given-names>C</given-names> </author><author><surname>Martinez-Lage</surname> <given-names>J</given-names> </author><author><surname>Soininen</surname> <given-names>H</given-names> </author><author><surname>Hofman</surname> <given-names>A</given-names> </author><title>Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic diseases in the elderly research group</title><source>Neurology</source><year>2000</year><volume>54</volume><fpage>4</fpage><lpage>9</lpage>
<author><surname>Mendez</surname> <given-names>MF</given-names> </author><author><surname>Mendez</surname> <given-names>MA</given-names> </author><author><surname>Martin</surname> <given-names>R</given-names> </author><author><surname>Smyth</surname> <given-names>KA</given-names> </author><author><surname>Whitehouse</surname> <given-names>PJ</given-names> </author><title>Complex visual disturbances in Alzheimer&#8217;s disease</title><source>Neurology</source><year>1990</year><volume>40</volume><fpage>439</fpage><lpage>443</lpage>
<author><surname>Holoryd</surname> <given-names>S</given-names> </author><author><surname>Sphepherd</surname> <given-names>ML</given-names> </author><title>Alzheimer&#8217;s disease: a review for the ophthalmologist</title><source>Surv Ophthalmol</source><year>2001</year><volume>45</volume><fpage>516</fpage><lpage>524</lpage>
<author><surname>Sadun</surname> <given-names>AA</given-names> </author><author><surname>Bassi</surname> <given-names>CJ</given-names> </author><title>The visual system in Alzheimer&#8217;s disease</title><source>Res Publ Assoc Res Nerv Ment Dis</source><year>1990</year><volume>67</volume><fpage>331</fpage><lpage>347</lpage>
<author><surname>Katz</surname> <given-names>B</given-names> </author><author><surname>Rimmer</surname> <given-names>S</given-names> </author><title>Ophthalmologic manifestations of Alzheimer&#8217;s disease</title><source>Surv Ophthalmol</source><year>1989</year><volume>34</volume><fpage>31</fpage><lpage>43</lpage>
<author><surname>Pelak</surname> <given-names>VS</given-names> </author><author><surname>Hall</surname> <given-names>DA</given-names> </author><title>Neuro-ophthalmic manifestations of neurodegenerative disease</title><source>Ophthalmol Clin North Am</source><year>2004</year><volume>17</volume><fpage>311</fpage><lpage>320</lpage>
<author><surname>Fletcher</surname> <given-names>WA</given-names> </author><title>Ophthalmological aspects of Alzheimer&#8217;s disease</title><source>Curr Opin Ophthalmol</source><year>1994</year><volume>5</volume><fpage>38</fpage><lpage>44</lpage>
<author><surname>Berisha</surname> <given-names>F</given-names> </author><author><surname>Feke</surname> <given-names>GT</given-names> </author><author><surname>Trempe</surname> <given-names>CL</given-names> </author><author><surname>McMeel</surname> <given-names>JW</given-names> </author><author><surname>Schepens</surname> <given-names>CL</given-names> </author><title>Retinal abnormalities in early Alzheimer&#8217;s disease</title><source>Invest Ophthalmol Vis Sci</source><year>2007</year><volume>48</volume><fpage>2285</fpage><lpage>2289</lpage>
<author><surname>Hinton</surname> <given-names>DR</given-names> </author><author><surname>Sadun</surname> <given-names>AA</given-names> </author><author><surname>Blanks</surname> <given-names>JC</given-names> </author><author><surname>Miller</surname> <given-names>CA</given-names> </author><title>Optic-nerve degeneration in Alzheimer&#8217;s disease</title><source>N Engl J Med</source><year>1986</year><volume>315</volume><fpage>485</fpage><lpage>487</lpage>
<author><surname>Danesh-Meyer</surname> <given-names>HV</given-names> </author><author><surname>Birch</surname> <given-names>H</given-names> </author><author><surname>Ku</surname> <given-names>JY</given-names> </author><author><surname>Carroll</surname> <given-names>S</given-names> </author><author><surname>Gamble</surname> <given-names>G</given-names> </author><title>Reduction of optic nerve fibers in patients with Alzheimer disease identified by laser imaging</title><source>Neurology</source><year>2006</year><volume>67</volume><fpage>1852</fpage><lpage>1854</lpage>
<author><surname>Syed</surname> <given-names>AB</given-names> </author><author><surname>Armstrong</surname> <given-names>RA</given-names> </author><author><surname>Smith</surname> <given-names>CU</given-names> </author><title>A quantitative analysis of optic nerve axons in elderly control subjects and patients with Alzheimer&#8217;s disease</title><source>Folia Neuropathol</source><year>2005</year><volume>43</volume><fpage>1</fpage><lpage>6</lpage>
<author><surname>Frederikse</surname> <given-names>PH</given-names> </author><author><surname>Garland</surname> <given-names>D</given-names> </author><author><surname>Zigler</surname> <given-names>JS</given-names> <suffix>Jr</suffix> </author><author><surname>Piatigorsky</surname> <given-names>J</given-names> </author><title>Oxidative stress increases production of beta-amyloid precursor protein and beta-amyloid (Abeta) in mammalian lenses, and Abeta has toxic effects on lens epithelial cells</title><source>J Biol Chem</source><year>1996</year><volume>271</volume><fpage>10169</fpage><lpage>10174</lpage>
<author><surname>Bruban</surname> <given-names>J</given-names> </author><author><surname>Glotin</surname> <given-names>AL</given-names> </author><author><surname>Dinet</surname> <given-names>V</given-names> </author><author><surname>Chalour</surname> <given-names>N</given-names> </author><author><surname>Sennlaub</surname> <given-names>F</given-names> </author><author><surname>Jonet</surname> <given-names>L</given-names> </author><author><surname>An</surname> <given-names>N</given-names> </author><author><surname>Faussat</surname> <given-names>AM</given-names> </author><author><surname>Mascarelli</surname> <given-names>F</given-names> </author><title>Amyloid-beta(1&#8211;42) alters structure and function of retinal pigmented epithelial cells</title><source>Aging Cell</source><year>2009</year><volume>8</volume><fpage>162</fpage><lpage>177</lpage>
<author><surname>Townes-Anderson</surname> <given-names>E</given-names> </author><author><surname>Vogt</surname> <given-names>BA</given-names> </author><title>Distribution of muscarinic acetylcholine receptors on processes of isolated retinal cells</title><source>J Comp Neurol</source><year>1989</year><volume>290</volume><fpage>369</fpage><lpage>383</lpage>
<author><surname>Katz</surname> <given-names>B</given-names> </author><author><surname>Rimmer</surname> <given-names>S</given-names> </author><author><surname>Iragui</surname> <given-names>V</given-names> </author><author><surname>Katzman</surname> <given-names>R</given-names> </author><title>Abnormal pattern electroretinogram in Alzheimer&#8217;s disease: evidence for retinal ganglion cell degeneration?</title><source>Ann Neurol</source><year>1989</year><volume>26</volume><fpage>221</fpage><lpage>225</lpage>
<author><surname>Trick</surname> <given-names>GL</given-names> </author><author><surname>Barris</surname> <given-names>MC</given-names> </author><author><surname>Bickler-Bluth</surname> <given-names>M</given-names> </author><title>Abnormal pattern electroretinogram in patients with senile dementia of the Alzheimer type</title><source>Ann Neurol</source><year>1989</year><volume>26</volume><fpage>226</fpage><lpage>231</lpage>
<author><surname>Parisi</surname> <given-names>V</given-names> </author><author><surname>Restuccia</surname> <given-names>R</given-names> </author><author><surname>Fattapposta</surname> <given-names>F</given-names> </author><author><surname>Mina</surname> <given-names>C</given-names> </author><author><surname>Bucci</surname> <given-names>MG</given-names> </author><author><surname>Pierelli</surname> <given-names>F</given-names> </author><title>Morphological and functional retinal impairment in Alzheimer&#8217;s disease patients</title><source>Clin Neurophysiol</source><year>2001</year><volume>112</volume><fpage>1860</fpage><lpage>1867</lpage>
<author><surname>Partanen</surname> <given-names>J</given-names> </author><author><surname>Hartikainen</surname> <given-names>P</given-names> </author><author><surname>K&#246;n&#246;nen</surname> <given-names>M</given-names> </author><author><surname>Jousm&#228;ki</surname> <given-names>V</given-names> </author><author><surname>Soinien</surname> <given-names>H</given-names> </author><author><surname>Riekkinen</surname> <given-names>P</given-names> </author><title>Prolonged latencies of pattern reversal visual evoked early potentials in Alzheimer disease</title><source>Alzheimer Dis Assoc Disord</source><year>1994</year><volume>8</volume><fpage>250</fpage><lpage>258</lpage>
<author><surname>Pollock</surname> <given-names>VE</given-names> </author><author><surname>Schneider</surname> <given-names>LS</given-names> </author><author><surname>Chui</surname> <given-names>HC</given-names> </author><author><surname>Henderson</surname> <given-names>V</given-names> </author><author><surname>Zemansky</surname> <given-names>M</given-names> </author><author><surname>Sloane</surname> <given-names>RB</given-names> </author><title>Visual evoked potentials in dementia: a meta-analysis and empirical study of Alzheimer&#8217;s disease patients</title><source>Biol Psychiatry</source><year>1989</year><volume>25</volume><fpage>1003</fpage><lpage>1013</lpage>
<author><surname>Grayson</surname> <given-names>AS</given-names> </author><author><surname>Weiler</surname> <given-names>EM</given-names> </author><author><surname>Sandman</surname> <given-names>DE</given-names> </author><title>Visual evoked potentials in early Alzheimer&#8217;s dementia: an exploratory study</title><source>J Gen Psychol</source><year>1995</year><volume>122</volume><fpage>113</fpage><lpage>129</lpage>
<author><surname>Kergoat</surname> <given-names>H</given-names> </author><author><surname>Kergoat</surname> <given-names>MJ</given-names> </author><author><surname>Justino</surname> <given-names>L</given-names> </author><author><surname>Chertkow</surname> <given-names>H</given-names> </author><author><surname>Robillard</surname> <given-names>A</given-names> </author><author><surname>Bergman</surname> <given-names>H</given-names> </author><title>Visual retinocortical function in dementia of the Alzheimer&#8217;s type</title><source>Gerontology</source><year>2002</year><volume>48</volume><fpage>197</fpage><lpage>203</lpage>
<author><surname>Rizzo</surname> <given-names>JF</given-names> <suffix>3rd</suffix> </author><author><surname>Cronin-Golomb</surname> <given-names>A</given-names> </author><author><surname>Growdon</surname> <given-names>JH</given-names> </author><author><surname>Corkin</surname> <given-names>S</given-names> </author><author><surname>Rosen</surname> <given-names>TJ</given-names> </author><author><surname>Sandberg</surname> <given-names>MA</given-names> </author><author><surname>Chiappa</surname> <given-names>KH</given-names> </author><author><surname>Lessell</surname> <given-names>S</given-names> </author><title>Retinocalcarine function in Alzheimer&#8217;s disease. A clinical and electrophysiological study</title><source>Arch Neurol</source><year>1992</year><volume>49</volume><fpage>93</fpage><lpage>101</lpage>
<author><surname>Strenn</surname> <given-names>K</given-names> </author><author><surname>Dal-Bianco</surname> <given-names>P</given-names> </author><author><surname>Weghaupt</surname> <given-names>H</given-names> </author><author><surname>Koch</surname> <given-names>G</given-names> </author><author><surname>Vass</surname> <given-names>C</given-names> </author><author><surname>Gottlob</surname> <given-names>I</given-names> </author><title>Pattern electroretinogram and luminance electroretinogram in Alzheimer&#8217;s disease</title><source>J Neural Transm Suppl</source><year>1991</year><volume>33</volume><fpage>73</fpage><lpage>80</lpage>
<author><surname>Iseri</surname> <given-names>P</given-names> </author><author><surname>Altina&#351;</surname> <given-names>&#214;</given-names> </author><author><surname>Tokay</surname> <given-names>T</given-names> </author><author><surname>Y&#369;skel</surname> <given-names>N</given-names> </author><title>Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease</title><source>J Neuro-Ophthalmol</source><year>2006</year><volume>26</volume><fpage>18</fpage><lpage>24</lpage>
<author><surname>Philpot</surname> <given-names>MP</given-names> </author><author><surname>Amin</surname> <given-names>D</given-names> </author><author><surname>Levy</surname> <given-names>R</given-names> </author><title>Visual evoked potentials in Alzheimer&#8217;s disease: correlation with age and severity</title><source>Electroencephalogr Clin Neurophysiol</source><year>1990</year><volume>77</volume><fpage>323</fpage><lpage>329</lpage>
<author><surname>McKhann</surname> <given-names>G</given-names> </author><author><surname>Drachman</surname> <given-names>D</given-names> </author><author><surname>Folstein</surname> <given-names>M</given-names> </author><author><surname>Katzman</surname> <given-names>R</given-names> </author><author><surname>Price</surname> <given-names>D</given-names> </author><author><surname>Stadlan</surname> <given-names>EM</given-names> </author><title>Clinical Diagnosis of Alzheimer&#8217;s disease: report of the NINCDS-ADRDA work group under the auspices of the department of health and human services task force on Alzheimer&#8217;s disease</title><source>Neurology</source><year>1984</year><volume>34</volume><fpage>939</fpage><lpage>944</lpage>
<author><surname>Folstein</surname> <given-names>MF</given-names> </author><author><surname>Folstein</surname> <given-names>SE</given-names> </author><author><surname>McHugh</surname> <given-names>PR</given-names> </author><title>Mini-mental state. A practical method for grading the cognitive state of patients for the clinician</title><source>J Psychiatr Res</source><year>1975</year><volume>12</volume><fpage>189</fpage><lpage>198</lpage>
<author><surname>Celesia</surname> <given-names>GG</given-names> </author><author><surname>Kaufman</surname> <given-names>D</given-names> </author><title>Pattern ERGs and visual evoked potentials in maculopathies and optic nerve diseases</title><source>Invest Ophthalmol Vis Sci</source><year>1985</year><volume>26</volume><fpage>726</fpage><lpage>735</lpage>
<author><surname>Celesia</surname> <given-names>GG</given-names> </author><author><surname>Kaufman</surname> <given-names>D</given-names> </author><author><surname>Cone</surname> <given-names>SB</given-names> </author><title>Simultaneous recording of pattern electroretinography and visual evoked potentials in multiple sclerosis. A method to separate demyelination from axonal damage to the optic nerve</title><source>Arch Neurol</source><year>1986</year><volume>43</volume><fpage>1247</fpage><lpage>1252</lpage>
<title>Guideline 5: guidelines for standard electrode position nomenclature</title><source>J Clin Neurophysiol</source><year>2006</year><volume>23</volume><fpage>107</fpage><lpage>110</lpage>
<author><surname>Holder</surname> <given-names>GH</given-names> </author><editor>Heckenlively JR , Arden GB</editor><title>The pattern electroretinogram</title><source>Principles and practice of clinical electrophysiology of vision</source><year>2006</year><issue>2</issue><other>Cambridge</other><publisher>MIT Press</publisher><fpage>341</fpage><lpage>351</lpage>
<author><surname>Viswanathan</surname> <given-names>S</given-names> </author><author><surname>Frishman</surname> <given-names>LJ</given-names> </author><author><surname>Robson</surname> <given-names>JG</given-names> </author><title>The uniform field and pattern ERG in macaques with experimental glaucoma: removal of spiking activity</title><source>Invest Ophthalmol Vis Sci</source><year>2000</year><volume>41</volume><fpage>2797</fpage><lpage>2810</lpage>
<author><surname>Holder</surname> <given-names>GH</given-names> </author><editor>Heckenlively JR , Arden GB</editor><title>Localizing lesions in the visual system</title><source>Principles and practice of clinical electrophysiology of vision</source><year>2006</year><issue>2</issue><other>Cambridge</other><publisher>MIT Press</publisher><fpage>505</fpage><lpage>517</lpage>
<author><surname>Eckstein</surname> <given-names>MB</given-names> </author><author><surname>Spalton</surname> <given-names>DJ</given-names> </author><author><surname>Holder</surname> <given-names>G</given-names> </author><title>Visual loss from central serous retinopathy in systemic lupus erythematosus</title><source>Br J Ophthalmol</source><year>1993</year><volume>77</volume><fpage>607</fpage><lpage>609</lpage>
<author><surname>Lam</surname> <given-names>BL</given-names> </author><editor>Lam BL</editor><title>Visual evoked potential</title><source>Electrophysiology of vision. Clinical testing and applications</source><year>2005</year><issue>1</issue><other>Boca Raton</other><publisher>Taylor&amp;Francis Group</publisher><fpage>123</fpage><lpage>135</lpage>
<author><surname>Bodis-Wollner</surname> <given-names>I</given-names> </author><author><surname>Antal</surname> <given-names>A</given-names> </author><editor>Heckenlively JR , Arden GB</editor><title>Optic nerve and central nervous dysfunctions: Parkinson&#8217;s disease and multiple sclerosis</title><source>Principles and practice of clinical electrophysiology of vision</source><year>2006</year><issue>2</issue><other>Cambridge</other><publisher>MIT Press</publisher><fpage>341</fpage><lpage>351</lpage>
<author><surname>Parisi</surname> <given-names>V</given-names> </author><author><surname>Pernini</surname> <given-names>C</given-names> </author><author><surname>Guinetti</surname> <given-names>C</given-names> </author><author><surname>Neuschuler</surname> <given-names>R</given-names> </author><author><surname>Bucci</surname> <given-names>MG</given-names> </author><title>Electrophysiological assessment of visual pathways in glaucoma</title><source>Eur J Ophthalmol</source><year>1997</year><volume>7</volume><fpage>229</fpage><lpage>235</lpage>
<author><surname>L&#246;ffler</surname> <given-names>KU</given-names> </author><author><surname>Edward</surname> <given-names>DP</given-names> </author><author><surname>Tso</surname> <given-names>MO</given-names> </author><title>Immunoreactivity against tau, amyloid precursor protein, and beta-amyloid in the human retina</title><source>Invest Ophthalmol Vis Sci</source><year>1995</year><volume>36</volume><fpage>24</fpage><lpage>31</lpage>
<author><surname>Liu</surname> <given-names>B</given-names> </author><author><surname>Rasool</surname> <given-names>S</given-names> </author><author><surname>Yang</surname> <given-names>Z</given-names> </author><author><surname>Glabe</surname> <given-names>CG</given-names> </author><author><surname>Schreiber</surname> <given-names>SS</given-names> </author><author><surname>Ge</surname> <given-names>J</given-names> </author><author><surname>Tan</surname> <given-names>Z</given-names> </author><title>Amyloid-peptide vaccinations reduce {beta}-amyloid plaques but exacerbate vascular deposition and inflammation in the retina of Alzheimer&#8217;s transgenic mice</title><source>Am J Pathol</source><year>2009</year><volume>175</volume><fpage>2099</fpage><lpage>2110</lpage>
<author><surname>Melo</surname> <given-names>JB</given-names> </author><author><surname>Agostinho</surname> <given-names>P</given-names> </author><author><surname>Oliveira</surname> <given-names>CR</given-names> </author><title>Amyloid beta-peptide 25&#8211;35 reduces [3H]acetylcholine release in retinal neurons. Involvement of metabolic dysfunction</title><source>Amyloid</source><year>2002</year><volume>9</volume><fpage>221</fpage><lpage>228</lpage>
<author><surname>Aruoma</surname> <given-names>OI</given-names> </author><author><surname>Jen</surname> <given-names>SS</given-names> </author><author><surname>Watts</surname> <given-names>HR</given-names> </author><author><surname>George</surname> <given-names>J</given-names> </author><author><surname>Gentleman</surname> <given-names>SM</given-names> </author><author><surname>Anderson</surname> <given-names>PJ</given-names> </author><author><surname>Jen</surname> <given-names>LS</given-names> </author><title>Acute and chronic effects of intravitreally injected beta-amyloid on the neurotransmitter system in the retina</title><source>Toxicology</source><year>2009</year><volume>256</volume><fpage>92</fpage><lpage>100</lpage>
<author><surname>Dimitrieva</surname> <given-names>NA</given-names> </author><author><surname>Christianne</surname> <given-names>ES</given-names> </author><author><surname>Kent</surname> <given-names>TK</given-names> </author><title>Expression of alpha 7 nicotinic acetylcholine receptors by bipolar, amacrine, and ganglion cells of the rabbit retina</title><source>J Histochem Cytochem</source><year>2007</year><volume>55</volume><fpage>461</fpage><lpage>476</lpage>